RecruitingNCT05946057
Otoferlin Patient Registry and Natural History Study
Patient Registry for Individuals With Otoferlin-Associated Hearing Loss
Sponsor
Tobias Moser
Enrollment
100 participants
Start Date
Feb 21, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This registry is designed to collect comprehensive information about the molecular genetic diagnoses of individuals with otoferlin-associated hearing impairment and clinical information to support a natural history study.
Eligibility
Inclusion Criteria1
- A molecular genetic diagnosis involving biallelic variants in otoferlin (OTOF) and audiometry
Exclusion Criteria1
- Patients with evidence of non-OTOF molecular genetic diagnoses
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTMolecular genetic testing and audiometry
Genetic testing and audiometry are the interventions of interest
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05946057
Related Trials
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
NCT073040241 location
CABP2 Patient Registry and Natural History Study
NCT066809341 location
Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
NCT058053841 location
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
NCT066639171 location
Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)
NCT058474265 locations